Back to Results
First PageMeta Content
Immune system / Chlamydiae / Pathogenic bacteria / Vaccination / Vaccine / Virology / Antibody / Chlamydophila pneumoniae / Biotechnology / Chlamydia / Antigen


Press Release GANYMED extended Research Collaboration with the Cantonal Hospital St. Gallen Mainz, November 18, 2003 GANYMED Pharmaceuticals AG, an independent biotechnology company that identifies and validates antigen
Add to Reading List

Document Date: 2015-02-04 05:15:01


Open Document

File Size: 13,81 KB

Share Result on Facebook